|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
������ |
|
����ø |
|
Ƥ������ |
| ��������������� | |
|
������ |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
�����غͿ���øB��Ƥ�����еı��
������, ����
�㽭��ѧҽѧԺ������һҽԺƤ����, ����310003
�����������øB��ϸ����ϸ���������õ���ҪЧӦ���ӡ��ڿ���������������������������ֲ�ų��о�����Ҫ���á�������������֢��Ƥ������Ƥ�������е������ܵ����ǵĹ�ע�������˴����������øB��һЩƤ�������е��о���չ��
[2] Trapani JA. Granzymes: a family of lymphocyte granule serine proteases. Genome Biol, 2001,2: S3014.
[3] Froelich C J, Dixit VM, Yang X. Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immunol Today,1998, 19:30-36.
[4] Yawalkar N, Schmid S, Braathen LR, et al. Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis.Br J Dermatol, 2001, 144:1133-1139.
[5] Pichler WJ, Yawalkar N, Britschgi M, et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol,2002,3:229-238.
[6] Yawalkar N, Pichler WJ. Immunohistology of drug-induced exanthema: clues to pathogenesis. Curr Opin Allergy Clin Immunol, 2001, 1:299-303.
[7] Posadas S J, Torres M J, Mayorga C, et al. Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs. Blood Cells Mol Dis, 2002, 29:179-189.
[8] Yawalkar N, Hunger RE, Buri C, et al. A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis: spongiotic skin lesions in allergic contact dermatitis are highly infiltrated by T cells expressing perforin and granzyme B. Am J Pathol, 2001, 158:803-808.
[9] Kehren J, Desvignes C, Krasteva M, et al. Cytotoxicity is mandatory for CD8 ( + ) T cell-mediated contact hypersensitivity. J Exp Med,1999, 189:779-786.
[10] Behrendt C, Gollnick H, Bonnekoh B. Up-regulated perforin expression of CD8 + blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psoriasis. Eur J Dermatol, 2000, 10: 365-369.
[11] Santoro A, Majorana A, Bardellini E, et al. Cytotoxic molecule expression and epithelial cell apoptosis in oral and cutaneous lichen planus. Am J Clin Pathol, 2004, 121:758-764.
[12] Gross T, Wagner A, Ugurel S, et al. Identification ofTIA-1 + and granzyme B + cytotoxic T cells in lichen sclerosus et atrophicus. Dermatology, 2001,202:198-202.
[13] Cherin P, Herson S, Crevon MC, et al. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheumatol, 1996,23:1135-1142.
[14] Vermeer MH, Geelen FA, Kummer JA, et al. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Am J Pathol, 1999,154:1203-1210.
[15] Asadullah K, Friedrich M, Haeubetaler A, et al. Granzyme A mRNA expression in mycosis fungoides progression. Blood, 1997, 90: 3810-3811.
[16] Boulland ML, Wechsler J, Bagot M, et al. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. Histopathology, 2000, 36:136-144.
[17] Kamarashev J, Burg G, Mingari MC, et al. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8 + and CD56 + cutaneous lymphomas. Am J Pathol, 2001, 158: 1593-1598.
[18] Cruz I, Meijer CJ, Walboomers JM, et al. Lack of MHC class �� surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas. Br J Cancer, 1999, 81:881-889.
[19] Yamamoto T, Yoneda K, Ueta E, et al. Enhanced apoptosis of squamous cell carcinoma cells by interleukin-2-activated cytotoxic lymphocytes combined with radiation and anticancer drugs. Eur J Cancer,2000, 36:2007-2017.
[20] Verhaegh ME, Wever PC, Neumann HA, et al. Immunohistochemical localization of granzyme B in peritumoral infiltrates of basal cell carcinoma. Br J Dermatol, 1997, 137:1012-1014.
[21] Barth C, Stachowski J, yon Menges A, et al. Limited T-cell repertoire in renal allograft and allogeneic melanoma transmitted by the graft.Transplantation, 1997, 64:1627-1630.
[22] Leger-Ravet MB, Mathiot C, Portier A, et al. Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2. Cancer Immunol Immunother, 1994, 39:53-58.